tetano
Editor, Senior Moderator
Wien Med Wochenschr
. 2022 Aug 8.
doi: 10.1007/s10354-022-00954-x. Online ahead of print.
The prevalence of vascular complications in SARS-CoV-2 infected outpatients
Yvonne Goßlau[SUP] 1 [/SUP], Tobias Dominik Warm[SUP] 2 [/SUP], Edgar Franklin Hernandez Cancino[SUP] 2 [/SUP], Inge Kirchberger[SUP] 3 [/SUP], Christine Meisinger[SUP] 3 [/SUP], Jakob Linseisen[SUP] 3 [/SUP], Alexander Hyhlik-Duerr[SUP] 2 [/SUP]
Affiliations
Abstract
in English, German
Background: The risk of thromboembolic events is increased for coronavirus disease (COVID)-19 inpatients. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected outpatients, only few data are available so far.
Methods: In our prospective single-center study, 461 SARS-CoV-2-infected outpatients were screened for the presence of deep vein thrombosis.
Results: Two outpatients had suffered a deep vein thrombosis. An association with previously known risk factors, such as preexisting thrombosis in the medical history or cardiovascular risk factors, could not be proven.
Conclusion: General thromboprophylaxis in SARS-CoV-2-infected outpatients is still not recommended.
Keywords: COVID-19; Mild illness; Outpatient treatment; SARS-CoV-2; Thrombosis prophylaxis.
. 2022 Aug 8.
doi: 10.1007/s10354-022-00954-x. Online ahead of print.
The prevalence of vascular complications in SARS-CoV-2 infected outpatients
Yvonne Goßlau[SUP] 1 [/SUP], Tobias Dominik Warm[SUP] 2 [/SUP], Edgar Franklin Hernandez Cancino[SUP] 2 [/SUP], Inge Kirchberger[SUP] 3 [/SUP], Christine Meisinger[SUP] 3 [/SUP], Jakob Linseisen[SUP] 3 [/SUP], Alexander Hyhlik-Duerr[SUP] 2 [/SUP]
Affiliations
- PMID: 35939218
- DOI: 10.1007/s10354-022-00954-x
Abstract
in English, German
Background: The risk of thromboembolic events is increased for coronavirus disease (COVID)-19 inpatients. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected outpatients, only few data are available so far.
Methods: In our prospective single-center study, 461 SARS-CoV-2-infected outpatients were screened for the presence of deep vein thrombosis.
Results: Two outpatients had suffered a deep vein thrombosis. An association with previously known risk factors, such as preexisting thrombosis in the medical history or cardiovascular risk factors, could not be proven.
Conclusion: General thromboprophylaxis in SARS-CoV-2-infected outpatients is still not recommended.
Keywords: COVID-19; Mild illness; Outpatient treatment; SARS-CoV-2; Thrombosis prophylaxis.